BCL2 and central nervous system cancer: Manzano et al. demonstrated that E2F1 modulated the expression of the anti-apoptotic molecule Bcl-2 and suggested that up-regulation of Bcl-2 might favor the oncogenic role of E2F1 and the other E2F family members in human glioma cells [45].